S
Silence Therapeutics plc (SLN)
NGM – Real Time Price. Currency in USD
10.14
+0.14 (1.40%)
At close: Jun 26, 2026, 4:00 PM EDT
10.07
-0.07 (-0.69%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
10.14
+0.14 (1.40%)
At close: Jun 26, 2026, 4:00 PM EDT
10.07
-0.07 (-0.69%)
After-hours: Jun 26, 2026, 7:50 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 9.83 | 6.05 | 10 | |
| Quick ratio | 9.83 | 5.63 | 10 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 8.2 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 22M | 32M | 43M | 560K | 840K |
| Gross Profit | 8M | 19M | 31M | -55K | 237K |
| Operating Income | -60M | -53M | -50M | -82M | -72M |
| Net Income | -50M | -54M | -45M | -89M | -75M |
| EBITDA | -59M | -52M | -49M | -82M | -71M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 421.53 | 27.02 | 10 |
| Next quarter | 617.54 | 13.96 | 9.0 |
| Current year | 499.46 | 15.22 | 9.5 |
| Next year | 37.81 | -17.06 | 5.5 |
| Weighted average score | 8.5 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 1140.89 | -27.04 | -22.21 | 9.81 | 4.5 |
| Y/Y | 195.55 | 47.86 | 45 | -26.01 | 7.8 |
| 3y average | -5.03 | -29.44 | -18.64 | -5.7 | 1.0 |
| 5y average | 30.83 | -22.03 | 4.39 | -141.12 | 4.0 |
| Weighted average score | 4.3 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $5.7M significantly exceed its total debt $136.0K, ensuring strong financial flexibility
Total current assets $102.9M exceed Total current liabilities $10.5M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$15.6M limits the company's ability to reinvest or pay down debt